Rice Hall James & Associates, LLC Care Dx, Inc. Transaction History

Rice Hall James & Associates, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$28.19 - $46.6 $843,529 - $1.39 Million	-29,923 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $41,200 - $73,600	-1,000 Reduced 3.23%	29,923 $1.36 Million
Q3 2021 Nov 09, 2021	BUY	$59.15 - $91.99 $7,334 - $11,406	124 Added 0.4%	30,923 $1.96 Million
Q2 2021 Jul 29, 2021	SELL	$63.02 - $95.11 $91,315 - $137,814	-1,449 Reduced 4.49%	30,799 $2.82 Million
Q1 2021 May 14, 2021	SELL	$57.62 - $95.6 $2.95 Million - $4.89 Million	-51,129 Reduced 61.32%	32,248 $2.2 Million

Q4 2020 Feb 16, 2021	SELL	$41.43 - $77.09 $5.38 Million - $10 Million	-129,849 Reduced 60.9%	83,377 $6.04 Million
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $2.39 Million - $2.94 Million	-77,486 Reduced 26.65%	213,226 $8.09 Million
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $1.29 Million - $2.41 Million	-68,145 Reduced 18.99%	290,712 $10.3 Million
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $2.48 Million - $5.03 Million	-178,086 Reduced 33.17%	358,857 $7.83 Million
Q4 2019 Jan 29, 2020	BUY	$19.24 - $28.41 $10.3 Million - $15.3 Million	536,943 New	536,943 $11.6 Million

150

55.1M

85.8K

48.8K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $797M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.